Skip to main content

Table 1 Baseline Demographics

From: Value of the platelet-to-lymphocyte ratio in the prediction of left ventricular thrombus in anterior ST-elevation myocardial infarction with left ventricular dysfunction

 

Whole cohort(n = 217)

LVT group(n = 46)

No LVT group(n = 92)

95%CI

P value

Baseline clinical characteristics

 Age (years)

61.01 ± 11.51

59.63 ± 11.75

61.01 ± 11.51

(0.964,1.030)

0.951

 Male sex, n (%)

173 (79.7)

36 (78.3)

173 (79.7)

(0.424,2.359)

1.000

 Smoker, n (%)

121 (55.8)

26 (56.5)

121 (55.8)

(0.353,1.497)

0.386

 HTN, n (%)

86 (39.6)

15 (32.6)

86 (39.6)

(0.275,1.208)

0.142

 DM, n (%)

45 (20.7)

9 (19.6)

45 (20.7)

(0.290,1.547)

0.588

 chest pain onset duration<12 h

123 (56.7)

17 (37)

123 (56.7)

(0.260,1.110)

0.091

Procedural characteristics

 DTBT (min) (means ± SD)

102.87 ± 91.82

141.87 ± 105.06

102.87 ± 91.82

(1.001,1.008)

0.005

 Thrombectomy n (%)

47 (21.7)

8 (17.4)

47 (21.7)

(0.305,1.881)

0.493

 Pre-PCI TIMI flowgrade

  0

172 (79.3)

33 (76.1)

172 (79.3)

–

0.155

  1

7 (3.2)

1 (2.15)

7 (3.2)

–

0.720

  2

8 (3.7)

1 (2.15)

8 (3.7)

–

1.000

  3

30 (18.4)

9 (19.6)

30 (18.4)

–

0.144

 post-PCI TIMI flowgrade =3

  0

0

0

0

–

_

  1

0

0

0

–

_

  2

10 (4.6)

1 (2.2)

10 (4.6)

–

1.000

  3

207 (95.4)

45 (97.8)

207 (95.4)

–

0.698

Blood examinations on admission

 WBC (× 109)

10.05 (8.22, 12.82)

10.7 (7.9, 13.6)

10.05 (8.22, 12.82)

(1.034,1.236)

0.062

 MPV (fl)

9.6 (9.0, 10.5)

9.6 (9.1, 10.7)

9.6 (9.0, 10.5)

(0.760,1.415)

0.748

 Platelets(×109)

197.5 (158.25, 251.75)

228 (164, 294)

197.5 (158.25, 251.75)

(0.999,1.009)

0.316

 Neutrophil(×109)

7.40 (5.60, 10.25)

7.30 (5.45, 10.17)

7.40 (5.60, 10.25)

(1.025,1.234)

0.059

 Lymphocyte(×109)

1.68 (1.25, 2.14)

1.41 (1.14, 2.25)

1.68 (1.25, 2.14)

(0.304,0.871)

0.001

 Monocyte(×109)

0.63 (0.46, 0.86)

0.58 (0.38, 0.75)

0.63 (0.46, 0.86)

(0.305,5.576)

0.430

 NLR

4.38 (2.76, 7.91)

4.37 (2.84, 8.23)

4.38 (2.76, 7.91)

(1.098,1.444)

0.001

 PLR

114.57 (90.79, 157.42)

129.6 (98.9194.7)

114.57 (90.79, 157.42)

(1.005,1.020)

0.001

 fibrinogen (mg/dl)

3.59 (3.03, 4.55)

4.1 (3.2, 5.6)

3.59 (3.03, 4.55)

(0.972,1.547)

0.044

Echocardiography

 LVEDD (mm)

48.25 (44.5, 53.64)

51.2 (48.1, 56.4)

48.25 (44.5, 53.64)

(1.012,1.128)

0.012

 LVEF, %, (means ± SD)

41.78 ± 6.72

39.84 ± 10.05

41.78 ± 6.72

(0.886,0.981)

0.138

 LV aneurysmn n (%)

19 (87.56)

15 (32.6)

19 (87.56)

(5.585,347.162)

0.001

  1. The chest pain onset duration referred to the period of the occurrence of acute myocardial infarction to admission
  2. HTN Hypertension, DM diabetes mellitus, TIMI thrombolysis in myocardial infarction, DTBT Door-to-balloon time, WBC White blood cell count, MPV Mean platelet volume, NLR Neutrophil /lymphocyte ratio, PLR Platelet/lymphocyte ratio, LVEF left ventricular ejection fraction, LVEDD left ventricular end-diastolic dimension, LV aneurysmn, left ventricular aneurysmn
  3. P value represents the results of univariate analysis between LVT group and no LVT group